Novartis highlights advances for patients with breast cancer and hematological diseas

		Cancer Friends Network > Types of Cancer > Breast Cancer
Novartis highlights advances for patients with breast cancer and hematological diseas

LinkBack

Thread Tools

Display Modes

#1 (permalink)

12-02-2011, 07:48 AM

cancerfr

Administrator

Join Date: Sep 2008

Posts: 47,390

Novartis highlights advances for patients with breast cancer and hematological diseas

Updated Phase III data from BOLERO-2 trial studying everolimus in women with ER+HER2- advanced breast cancer Tasigna ® Phase III trials in Ph+ CML including 36-month follow-up data in newly diagnosed patients ...

Tim Pearson

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On Forum Rules

All times are GMT. The time now is 02:12 AM.

CancerFriends.net